Update on BTK inhibitors for CLL: Ibrutinib pus the new kids on the block: Are they better?

Update on BTK inhibitors for CLL: Ibrutinib pus the new kids on the block: Are they better?

User Photo
HMP CME

1 year
122 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Earn CME: https://naccme.com/program/7314

In this presentation from the 'Navigating the Evolving Therapeutic Landscape of CLL: Strategies for the Optimal Application of Emerging Agents and Combinations in Practice symposium, Dr. John C. Byrd provides an update on BTK inhibitors for CLL.

© 2018 Imedex, an HMP Company
Up Next Autoplay